C. Marra

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Neurocognitive Impact of Substance Use in HIV Infection

I. Grant, R. Heaton, D. Clifford, 2011, Journal of acquired immune deficiency syndromes.

Cerebrospinal fluid testing for the diagnosis of central nervous system infection.

C. Marra, J. Zunt, 1999, Neurologic clinics.

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

Anthony Gamst, Justin C McArthur, Ian Abramson, 2014, Neurology.

Diagnosing Symptomatic HIV-Associated Neurocognitive Disorders: Self-Report Versus Performance-Based Assessment of Everyday Functioning

I. Grant, R. Heaton, D. Clifford, 2011, Journal of the International Neuropsychological Society.

Defining Neurocognitive Impairment in HIV: Deficit Scores Versus Clinical Ratings

I. Grant, R. Heaton, D. Clifford, 2012, The Clinical neuropsychologist.

Diagnostic Dilemma of a Young Man With Fever and Headaches

C. Marra, S. Khot, Arielle P. Davis, 2012, The Neurohospitalist.

Research advances in neurological infections in 2017

C. Marra, 2018, The Lancet Neurology.

An experimental model of early central nervous system syphilis.

C. Marra, E. Hook, S. Lukehart, 1991, The Journal of infectious diseases.

A Cluster of Ocular Syphilis Cases - Seattle, Washington, and San Francisco, California, 2014-2015.

M. Golden, C. Marra, R. N. Fanfair, 2015, MMWR. Morbidity and mortality weekly report.

Toll-Like Receptor Polymorphisms Are Associated With Increased Neurosyphilis Risk

C. Marra, T. Hawn, L. Tantalo, 2014, Sexually transmitted diseases.

Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis.

C. Marra, L. Tantalo, S. Lukehart, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter?

C. Marra, L. Tantalo, J. Corbett, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat

D. Richman, R. Heaton, D. Clifford, 2012, Journal of NeuroVirology.

Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.

Sergei L. Kosakovsky Pond, D. Richman, I. Grant, 2012, Virology.

Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy

F. Vaida, I. Grant, J. Keltner, 2015, Pain.

Molecular Typing of Treponema pallidum in Ocular Syphilis

Robyn Neblett Fanfair, C. Marra, L. Tantalo, 2016, Sexually transmitted diseases.

Prevalence Estimates of Complicated Syphilis.

M. Golden, C. Marra, R. Kerani, 2015, Sexually transmitted diseases.

Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.

F. Vaida, I. Grant, B. Ances, 2010, Archives of neurology.

A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age

T. Ernst, Eric Miller, L. Chang, 2004, NeuroImage.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States

I. Grant, R. Heaton, D. Clifford, 2017, Journal of the International Neuropsychological Society.

Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years

R. Heaton, D. Clifford, R. Ellis, 2022, Brain, behavior, & immunity - health.

Genome‐wide association study of HIV‐associated neurocognitive disorder (HAND): A CHARTER group study

Zhongming Zhao, N. Schork, P. Jia, 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Types of Stroke Among People Living With HIV in the United States.

Richard D Moore, Rizwan Kalani, J. A. Delaney, 2021, Journal of acquired immune deficiency syndromes.

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy

F. Vaida, C. Fennema-Notestine, R. Heaton, 2017, The Journal of infectious diseases.

Memantine for AIDS Dementia Complex: Open-Label Report of ACTG 301

S. Lipton, Linda Chang, R. Ellis, 2010, HIV clinical trials.

International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271

C. Marra, N. Sacktor, K. Robertson, 2016, Journal of NeuroVirology.

Concurrent Classification Accuracy of the HIV Dementia Scale for HIV-Associated Neurocognitive Disorders in the CHARTER Cohort

I. Grant, R. Heaton, D. Clifford, 2013, Journal of acquired immune deficiency syndromes.

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection

C. Yiannoutsos, M. Max, D. Clifford, 1998, Neurology.

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

I. Grant, B. Ances, R. Heaton, 2012, Neurology.

Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions.

H. Hartung, B. Hemmer, C. Marra, 2007, Archives of neurology.

Treponema pallidum strain-specific differences in neuroinvasion and clinical phenotype in a rabbit model.

C. Marra, L. Tantalo, S. Lukehart, 2005, The Journal of infectious diseases.

Relapse of Secondary Syphilis After Benzathine Penicillin G: Molecular Analysis

C. Marra, R. Harrington, H. Bashiri, 2004, Sexually transmitted diseases.

INFECTIONS OF THE CENTRAL NERVOUS SYSTEM IN PATIENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS

C. Marra, 2006 .

Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.

Suzanne A. Moseley, F. Vaida, I. Grant, 2011, The Journal of neuropsychiatry and clinical neurosciences.

Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV

R. Heaton, D. Clifford, R. Ellis, 2020, Brain, behavior, & immunity - health.

Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.

T. Montine, S. Cepok, B. Hemmer, 2009, Archives of neurology.

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.

I. Grant, D. Clifford, R. Ellis, 2013, The Journal of antimicrobial chemotherapy.

Previous Syphilis Alters the Course of Subsequent Episodes of Syphilis.

C. Marra, L. Tantalo, S. Lukehart, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Previous Syphilis Alters the Course of Subsequent Episodes of Syphilis.

C. Marra, L. Tantalo, S. Lukehart, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative genomics and full-length Tprk profiling of Treponema pallidum subsp. pallidum reinfection

C. Marra, A. Addetia, Michelle J. Lin, 2019, bioRxiv.

Detection of Treponema pallidum DNA in Oropharyngeal Swabs and Whole Blood for Syphilis Diagnosis

D. Katz, C. Marra, L. Tantalo, 2021, Sexually transmitted diseases.

Ocular syphilis among HIV-infected individuals.

G. Robbins, C. Marra, Jonathan Z. Li, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Déjà vu all over again: when to perform a lumbar puncture in HIV-infected patients with syphilis.

C. Marra, 2007, Sexually transmitted diseases.

Macrolide Resistance in Treponema pallidum Correlates With 23S rDNA Mutations in Recently Isolated Clinical Strains

C. Marra, B. Molini, L. Tantalo, 2016, Sexually transmitted diseases.

Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?

C. Marra, K. Robertson, L. Tantalo, 2021, PloS one.

A Dual-Platform Point-of-Care Test for Neurosyphilis Diagnosis

C. Marra, L. Tantalo, I. Koralnik, 2021, Sexually transmitted diseases.

Hearing loss in individuals at risk for neurosyphilis

C. Marra, L. Tantalo, M. Ramchandani, 2020, International journal of STD & AIDS.

Treponemal tests for neurosyphilis--less accurate than what we thought?

C. Marra, E. Ho, 2012, Sexually transmitted diseases.

Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy

C. Marra, A. Collier, K. Robertson, 2007, BMC infectious diseases.

Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.

F. Vaida, I. Grant, D. Clifford, 2019, The lancet. HIV.

Neurosyphilis

C. Marra, 2015, Continuum.

Headache in HIV‐Infected Patients: Much to Consider

C. Marra, 2014, Headache.

Neurocognitive impairment in HIV-infected individuals with previous syphilis

I. Grant, R. Heaton, D. Clifford, 2013, International journal of STD & AIDS.

Serum Neurofilament Light in Neurosyphilis: A Pilot Study

H. Zetterberg, C. Marra, L. Tantalo, 2022, Sexually transmitted diseases.

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER

I. Grant, D. Clifford, M. Ritchie, 2012, Journal of NeuroVirology.

Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.

C. Marra, C. Marra, R. Price, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cognitive risk factors and neuropsychological performance in HIV infection.

C. Marra, W. Longstreth, A. Collier, 1993, The International journal of neuroscience.

Altered CD 4 / CD 8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis

A. Bar-Or, F. Grand'Maison, S. Cepok, 2006 .

A randomized clinical trial of CPI-1189 for HIV-associated cognitive–motor impairment

K. Marder, D. Clifford, M. Mcdermott, 2002, Neurology.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

F. Vaida, C. Fennema-Notestine, A. Gamst, 2013, Journal of NeuroVirology.

Syphilis

C. Marra, M. Ramchandani, Chase A. Cannon, 2023, Infectious Disease Clinics of North America.

Syphilis and Human Immunodeficiency Virus Infection

C. Marra, 1992 .

The Role of Cohort Studies in Drug Development: Clinical Evidence of Antiviral Activity of Serotonin Reuptake Inhibitors and HMG-CoA Reductase Inhibitors in the Central Nervous System

I. Grant, R. Heaton, D. Clifford, 2007, Journal of Neuroimmune Pharmacology.

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates

Jessica L. Montoya, D. Jeste, I. Grant, 2019, Journal of the International Neuropsychological Society.

Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study

R. Crum, I. Grant, D. Clifford, 2016, Journal of NeuroVirology.

Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study.

R. Heaton, D. Clifford, R. Ellis, 2022, Brain : a journal of neurology.

Relationships Among Neurocognitive Status, Medication Adherence Measured by Pharmacy Refill Records, and Virologic Suppression in HIV-Infected Persons

I. Grant, J. McCutchan, J. Atkinson, 2013, Journal of acquired immune deficiency syndromes.

Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.

C. Marra, C. Hall, N. Sacktor, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bell's palsy and HSV‐1 infection

C. Marra, 1999, Muscle & nerve.

HLA Gene Loci Associated with HIV Load in CSF and Blood Plasma in the CHARTER Cohort

F. Vaida, I. Grant, D. Clifford, 2014 .

Otosyphilis: A Review of the Literature

C. Marra, M. Ramchandani, Jamie R Litvack, 2020, Sexually transmitted diseases.

Elevated Plasma von Willebrand Factor Levels Are Associated With Subsequent Ischemic Stroke in Persons With Treated HIV Infection

Jeffrey N. Martin, M. Wurfel, C. Marra, 2021, Open forum infectious diseases.

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection

I. Grant, R. Heaton, J. Connor, 2018, Molecular Neurobiology.

Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation

I. Grant, R. Heaton, D. Clifford, 2015, Journal of acquired immune deficiency syndromes.

Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people

F. Vaida, I. Grant, R. Heaton, 2015, Neurology.

Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients

F. Vaida, I. Grant, R. Heaton, 2016, Journal of NeuroVirology.

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

D. Clifford, R. Ellis, C. Marra, 2009, AIDS.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

I. Grant, D. Murdock, R. Heaton, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV Viremia and Risk of Stroke Among People Living with HIV Who Are Using Antiretroviral Therapy

Richard D Moore, Rizwan Kalani, S. Heckbert, 2021, Epidemiology.

HIV-associated dementia [3] (multiple letters)

E. Major, C. Marra, J. McArthur, 2000 .

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

F. Vaida, C. Fennema-Notestine, A. Gamst, 2013, Journal of NeuroVirology.

Relationship of Medication Management Test-Revised (MMT-R) Performance to Neuropsychological Functioning and Antiretroviral Adherence in Adults with HIV

I. Grant, R. Heaton, D. Clifford, 2012, AIDS and Behavior.

HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings.

C. Marra, C. Hall, N. Sacktor, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Zhongming Zhao, P. Jia, I. Grant, 2016, The Journal of infectious diseases.

Brain morphometric correlates of metabolic variables in HIV: the CHARTER study

C. Fennema-Notestine, T. Jernigan, I. Grant, 2014, Journal of NeuroVirology.

Therapeutic Amprenavir Concentrations in Cerebrospinal Fluid

I. Grant, D. Clifford, R. Ellis, 2012, Antimicrobial Agents and Chemotherapy.

HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction.

C. Marra, R. Price, U. Lalloo, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Psychometric validation of the BDI-II among HIV-positive CHARTER study participants.

R. Heaton, C. Marra, M. Earleywine, 2015, Psychological assessment.

Case 25-2022: A 25-Year-Old Woman with Headache and Blurred Vision.

C. Marra, S. Rohatgi, Allyson K. Bloom, 2022, The New England journal of medicine.

Spinal Cord Disease

C. Marra, M. Previti, 2011 .

Selegiline and oxidative stress in HIV-associated cognitive impairment

C. Yiannoutsos, T. Ernst, D. Clifford, 2009, Neurology.

Selegiline Transdermal System (STS) for HIV-Associated Cognitive Impairment: Open-Label Report of ACTG 5090

D. Clifford, R. Ellis, C. Marra, 2007, HIV clinical trials.

HIV-associated neurocognitive disorders and central nervous system drug penetration: what next?

C. Marra, 2015, Antiviral therapy.

Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining “symptomatic” versus “asymptomatic” HAND

F. Vaida, C. Fennema-Notestine, I. Grant, 2016, Journal of NeuroVirology.

International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271

C. Marra, N. Sacktor, K. Robertson, 2016, Journal of Neurovirology.

A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings

C. Marra, R. Price, C. Hall, 2011, Journal of NeuroVirology.

Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat

D. Richman, I. Grant, R. Heaton, 2012, Journal of NeuroVirology.

Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy

C. Marra, A. Collier, J. Zunt, 2003, Neurology.

F. Vaida, I. Grant, J. Keltner, 2012, Psychosomatics.

Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1

F. Vaida, I. Grant, D. Clifford, 2010, Antimicrobial Agents and Chemotherapy.

Encephalitis in the 21 st century.

C. Marra, 2000, Seminars in neurology.

Memantine for AIDS dementia complex

S. Lipton, Linda Chang, R. Ellis, 2010 .

White matter damage, neuroinflammation, and neuronal integrity in HAND

C. Fennema-Notestine, I. Grant, R. Heaton, 2018, Journal of NeuroVirology.

Stroke in a patient with human immunodeficiency virus and syphilis treated with penicillin and antiretroviral therapy.

M. Golden, C. Marra, A. Heald, 2011, Sexually transmitted diseases.

Chronic Meningitis

C. Marra, Crispin Wilhelm, 1992, Seminars in neurology.

Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV

R. Heaton, D. Clifford, N. Calcutt, 2020, Annals of clinical and translational neurology.

Infections of the central nervous system.

C. Marra, W. Scheld, R. Whitley, 1991, Advances in internal medicine.

Diagnosis of neurosyphilis in HIV-negative patients with syphilis: development, validation, and clinical utility of a suite of machine learning models

C. Marra, Lixia Huang, H. Zou, 2023, EClinicalMedicine.

Infectious and Postinfectious Vasculopathies

C. Marra, 2023, Neuroimaging Clinics of North America.

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals

F. Vaida, C. Fennema-Notestine, B. Ances, 2016, Journal of Neurovirology.

Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIV

D. Clifford, R. Ellis, C. Marra, 2023, Viruses.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

I. Grant, R. Heaton, D. Clifford, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Macrolide resistance in Treponema pallidum in the United States and Ireland.

J. Klausner, C. Marra, B. Molini, 2004, The New England journal of medicine.

Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study

R. Crum, I. Grant, D. Clifford, 2016, Journal of NeuroVirology.

Low Cerebrospinal Fluid Concentrations of the Nucleotide HIV Reverse Transcriptase Inhibitor, Tenofovir

I. Grant, D. Clifford, R. Ellis, 2012, Journal of acquired immune deficiency syndromes.

Stroke in a patient with human immunodeficiency virus and syphilis treated with penicillin and antiretroviral therapy.

M. Golden, C. Marra, A. Heald, 2011, Sexually Transmitted Diseases.

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

D. Clifford, R. Ellis, C. Marra, 2009, AIDS.

Reply to Haddow et al.

F. Vaida, C. Fennema-Notestine, A. Gamst, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Michael J. Taylor, C. Fennema-Notestine, T. Jernigan, 2010, Journal of NeuroVirology.

Clinical factors related to brain structure in HIV: the CHARTER study

Michael J. Taylor, C. Fennema-Notestine, T. Jernigan, 2011, Journal of NeuroVirology.

Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1

F. Vaida, I. Grant, D. Clifford, 2010, Antimicrobial Agents and Chemotherapy.

Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.

T. Montine, S. Cepok, B. Hemmer, 2009, Archives of neurology.

Etravirine in CSF is highly protein bound.

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2013, The Journal of antimicrobial chemotherapy.